Home
MyCare - Patients: View your medical records securely online here.
Log in Learn More

Cancer

« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 10 of 17
Chawla
Sheema Chawla, MD
Quality of Life Assessment as a Predictor of Survival in Lung Cancer
RPCI I 22561
Peter Bushunow, MD
A Phase II Study of Single Agent Topoisomerase – I inhibitor Polymer Conjugate, Etirinotecan Pegol (NKTR – 102), in Patients with Relapsed Small Cell Lung Cancer
Acerta Pharma ACE - MY - 001
Saad Jamshed, MD
An Open label, Phase 1b Study of ACP - 196 in Subjects with Multiple Myeloma
CELGENE ABRAXANE
Mehul Patel, MD
A Phase III, randomized, open label, cross-over, multi-center, safety and efficacy study to evaluate nab-paclitaxel (Abraxane) as maintenance treatment after induction with nab-paclitaxel plus carboplatin in subjects with squamous cell non- small cell lung cancer (NSCLC)
ECOG ACRIN E4512
Mehul Patel, MD
A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
LILLY I3Y MC JPBL Breast
Peter Bushunow, MD
A Randomised, double-blind, placebo-controlled, -Phase 3 study of fluvestrant with or without LY2835219, a CDK4/6 inhibitor, for women with hormone receptor positive, HER2 negative metastatic breast cancer and disease progression after prior endocrine therapy.
URCC RSRB 52307
Peter Bushunow, MD
Examining the Role of Clara Cell Secretory Protein as a Clinical Marker for Radiation-Induced Lung Injury in Lung Cancer Patients receiving Radiotherapy
ALLIANCE A151216
Mehul Patel, MD
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
CLL REGISTRY
Peter Kouides, MD
Collection of specimens and epidemiological and clinical outcomes data in patients with hematological malignancies
« Previous 12 Next »